Coronavirus

As the covid-19 pandemic strains people and the economy, some venture capitalists are walking the talk on being responsible members of the community, the latest being Flourish Ventures.

VC dealmaking remained robust during the first three months of the year, but this trend is likely already reversing, according to the latest report from PitchBook and NVCA.

TCRS invested $150 million toward General Catalyst's latest funds, which totaled $2.3 billion. The pension system held its March board meeting via Zoom.

A VC analyst with Thomvest Ventures looks at what will happen to deal activity and valuations in the short term following the pandemic.

The new coronavirus reality has left consumer investors in an environment of distinct highs and lows, as some sectors surge while others slump.

Amid the covid-19 outbreak, four biotech funds closed on $3.8 billion in over a week and a half.

Australia's M8 Ventures, which was trying to raise $6.2m, says it has gone 'into sleep mode until there is more certainty in the economy.'

Wellcome Trust is not letting the covid-19 pandemic put a chill on its investing. The $33 billion foundation today re-upped with a healthcare venture capital fund, and it is well-positioned for future investments, says p rincipal Geoffrey Love.

Ridesharing and micromobility users are dropping amidst the virus and funding into autonomous vehicles is paused.